Endotoxin and Plasminogen Activator Inhibitor‐1 Serum Levels Associated With Nonalcoholic Steatohepatitis in Children
- 1 June 2010
- journal article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 50 (6) , 645-649
Abstract
Objectives: Recent evidence supports a role for endotoxemia in the progression from nonalcoholic fatty liver disease (NAFLD) to nonalcoholic steatohepatitis (NASH). We investigated the association between serum levels of endotoxin, proinflammatory molecules, and histology in children with NAFLD.Patients and Methods: A total of 40 children, mean age of 11.9 ± 2.8 years (27 male and 13 female), with biopsy‐proven NAFLD were consecutively enrolled. Anthropometrics, blood pressure, and parameters of the metabolic syndrome were collected. Serum levels of endotoxin, plasminogen activator inhibitor‐1 (PAI‐1), tumor necrosis factor (TNF)‐α, and interleukin (IL)‐6 were measured by an enzyme‐linked immunosorbent assay and compared with circulating levels of the same soluble factors in 9 age‐ and sex‐matched normal weight controls (age 11.4 ± 1.7 years; 6 boys and 3 girls).Results: Children with NAFLD had markedly higher serum concentrations of endotoxin (P < 0.01), PAI‐1 (P < 0.001), TNF‐α, and IL‐6 (P < 0.05) than control subjects. Endotoxin (P = 0.002), PAI‐1, (P < 0.001), IL‐6 (P = 0.002), TNF‐α (P = 0.02), and body mass index (P = 0.03) were significantly associated with a NAFLD activity score ≥5 at the univariate analysis. At the stepwise regression analysis, endotoxin (P < 0.0001) and PAI‐1 (P = 0.009) were the most significant predictors for NAFLD activity score.Conclusions: Our findings demonstrate that, apart from TNF‐α and IL‐6, endotoxin and PAI‐1 may represent good markers of NASH. They also reinforce the hypothesis that elevated levels of endotoxin may contribute to the progression from NAFLD to NASH.Keywords
This publication has 31 references indexed in Scilit:
- Nonalcoholic fatty liver disease: A manifestation of the metabolic syndromeCleveland Clinic Journal of Medicine, 2008
- Review article: epidemiology, pathogenesis and potential treatments of paediatric non‐alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics, 2008
- Non-alcoholic fatty liver disease: The mist gradually clearsJournal of Hepatology, 2008
- Pathology of Nonalcoholic Fatty Liver DiseaseAmerican Journal of Clinical Pathology, 2007
- Pediatric nonalcoholic fatty liver disease (NAFLD): A “growing” problem?Journal of Hepatology, 2007
- Epidemiology and Natural History of NAFLD and NASHClinics in Liver Disease, 2007
- Genes or environment to determine alcoholic liver disease and non‐alcoholic fatty liver diseaseLiver International, 2006
- Pediatric Nonalcoholic Fatty Liver DiseaseJournal of Pediatric Gastroenterology and Nutrition, 2006
- Nonalcoholic Fatty Liver Disease in ChildrenClinics in Liver Disease, 2005
- Histopathology of Pediatric Nonalcoholic Fatty Liver Disease * #Hepatology, 2005